Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market BuysNovember 10, 2025
Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO